Cell & Gene Meeting on the Mediterranean (MED) Híbrido (20-22 abril, Barcelona / 26-27 abril, virtual Partnering) Del 20/04/2022 to 27/04/2022 Healthcare
Integra Therapeutics appoints recognized geneticist George Church to its Scientific Adviso... 22/02/2022 Healthcare Talento Key to advancing development of the FiCAT gene writing platform, which aims to resolve the main limitations of gene... Partners - Integra Therapeutics S.L.
Natac is now organic certified! 17/02/2022 Healthcare Agrifood Agriculture BioSpain Corporate Natac has officially announced that the Hervás manufacturing facility received its organic certification. The... Partners - Natac Group
Oncology, focus of research among AseBio members for past 15 years 04/02/2022 Healthcare 59% of drugs (277 lines of research at national companies and multinational corporations with a subsidiary in Spain)... AseBio
European Healthtech CEO Forum for Partnering & Investment (EHTF) On-line Del 28/02/2022 to 28/02/2022 Healthcare Financing
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology 14/01/2022 Healthcare Gene editing Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the... Partners - Bayer Hispania S.L
Introducing Illumina Connected Analytics 07/01/2022 Healthcare Agrifood Gene editing International Analyze, manage, aggregate, and explore data at scale with Illumina Connected Analytics, a comprehensive, secure, cloud... Partners - Illumina
ORYZON announces approval for Serbian arm of PORTICO, vafidemstat’s Phase IIb trial in Bor... 04/01/2022 Healthcare Serbian arm final deployment in PORTICO. Study already active in Spain, Bulgaria, Germany and USA Partners - Oryzon Genomics
ORYZON to hold multiple corporate activities in January 03/01/2022 Healthcare Advanced therapies 40º Annual J.P. Morgan Healthcare Conference Biotech Showcase 2022 11º Annual LifeSci Partners Corporate Access Event... Partners - Oryzon Genomics
